200 related articles for article (PubMed ID: 31001488)
1. Activity of a Synthetic Peptide Targeting MgtC on
Moussouni M; Nogaret P; Garai P; Ize B; Vivès E; Blanc-Potard AB
Front Cell Infect Microbiol; 2019; 9():84. PubMed ID: 31001488
[TBL] [Abstract][Full Text] [Related]
2. Synthetic hydrophobic peptides derived from MgtR weaken Salmonella pathogenicity and work with a different mode of action than endogenously produced peptides.
Olvera MR; Garai P; Mongin G; Vivès E; Gannoun-Zaki L; Blanc-Potard AB
Sci Rep; 2019 Oct; 9(1):15253. PubMed ID: 31649255
[TBL] [Abstract][Full Text] [Related]
3. Use of the Salmonella MgtR peptide as an antagonist of the Mycobacterium MgtC virulence factor.
Belon C; Rosas Olvera M; Vives E; Kremer L; Gannoun-Zaki L; Blanc-Potard AB
Future Microbiol; 2016; 11(2):215-25. PubMed ID: 26849775
[TBL] [Abstract][Full Text] [Related]
4. A Macrophage Subversion Factor Is Shared by Intracellular and Extracellular Pathogens.
Belon C; Soscia C; Bernut A; Laubier A; Bleves S; Blanc-Potard AB
PLoS Pathog; 2015 Jun; 11(6):e1004969. PubMed ID: 26080006
[TBL] [Abstract][Full Text] [Related]
5. Intracellular phase for an extracellular bacterial pathogen: MgtC shows the way.
Bernut A; Belon C; Soscia C; Bleves S; Blanc-Potard AB
Microb Cell; 2015 Aug; 2(9):353-355. PubMed ID: 28357311
[No Abstract] [Full Text] [Related]
6. Peptide-assisted degradation of the Salmonella MgtC virulence factor.
Alix E; Blanc-Potard AB
EMBO J; 2008 Feb; 27(3):546-57. PubMed ID: 18200043
[TBL] [Abstract][Full Text] [Related]
7. Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants.
Garai P; Berry L; Moussouni M; Bleves S; Blanc-Potard AB
PLoS Pathog; 2019 Jun; 15(6):e1007812. PubMed ID: 31220187
[TBL] [Abstract][Full Text] [Related]
8. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
[TBL] [Abstract][Full Text] [Related]
9. The Versatile Pseudomonas aeruginosa Biofilm Matrix Protein CdrA Promotes Aggregation through Different Extracellular Exopolysaccharide Interactions.
Reichhardt C; Jacobs HM; Matwichuk M; Wong C; Wozniak DJ; Parsek MR
J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661078
[No Abstract] [Full Text] [Related]
10. A Survival Strategy for Pseudomonas aeruginosa That Uses Exopolysaccharides To Sequester and Store Iron To Stimulate Psl-Dependent Biofilm Formation.
Yu S; Wei Q; Zhao T; Guo Y; Ma LZ
Appl Environ Microbiol; 2016 Nov; 82(21):6403-6413. PubMed ID: 27565622
[TBL] [Abstract][Full Text] [Related]
11. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.
Skariyachan S; Sridhar VS; Packirisamy S; Kumargowda ST; Challapilli SB
Folia Microbiol (Praha); 2018 Jul; 63(4):413-432. PubMed ID: 29352409
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of extracellular polymeric substances in Pseudomonas aeruginosa biofilm development.
Yang L; Hu Y; Liu Y; Zhang J; Ulstrup J; Molin S
Environ Microbiol; 2011 Jul; 13(7):1705-17. PubMed ID: 21605307
[TBL] [Abstract][Full Text] [Related]
13. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
[TBL] [Abstract][Full Text] [Related]
14. Dual role of the MgtC virulence factor in host and non-host environments.
Rang C; Alix E; Felix C; Heitz A; Tasse L; Blanc-Potard AB
Mol Microbiol; 2007 Jan; 63(2):605-22. PubMed ID: 17176255
[TBL] [Abstract][Full Text] [Related]
15. Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro.
Vijayakumar K; Ramanathan T
J Ethnopharmacol; 2020 Jan; 246():112242. PubMed ID: 31533077
[TBL] [Abstract][Full Text] [Related]
16. Selective reactivity of monochloramine with extracellular matrix components affects the disinfection of biofilm and detached clusters.
Xue Z; Lee WH; Coburn KM; Seo Y
Environ Sci Technol; 2014 Apr; 48(7):3832-9. PubMed ID: 24575887
[TBL] [Abstract][Full Text] [Related]
17. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
18. Peptide transporter YjiY influences the expression of the virulence gene mgtC to regulate biofilm formation in Salmonella.
Chandra K; Garai P; Chatterjee J; Chakravortty D
FEMS Microbiol Lett; 2017 Dec; 364(24):. PubMed ID: 29112725
[TBL] [Abstract][Full Text] [Related]
19. Effects of the Selected Iminosugar Derivatives on Pseudomonas aeruginosa Biofilm Formation.
Strus M; Mikołajczyk D; Machul A; Heczko PB; Chronowska A; Stochel G; Gallienne E; Nicolas C; Martin OR; Kyzioł A
Microb Drug Resist; 2016 Dec; 22(8):638-645. PubMed ID: 27031025
[TBL] [Abstract][Full Text] [Related]
20. Psl Produced by Mucoid
Jones CJ; Wozniak DJ
mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
